Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
Tramadol is widely used globally and is the second most prescribed opioid in the United States. It treats moderate to severe pain but lethal opioid-induced respiratory depression is uncommon even in large overdose. It is unknown why tramadol spares respiration. Here we show its active metabolite, de...
Main Authors: | John A. Zebala, Aaron D. Schuler, Stuart J. Kahn, Dean Y. Maeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01680/full |
Similar Items
-
A Critical Review of the Pharmacokinetics and Pharmacodynamics of Opioid Medications Used in Avian Patients
by: Evelyn Aliansyah, et al.
Published: (2021-12-01) -
Comparison of an Addictive Potential of μ-Opioid Receptor Agonists with G Protein Bias: Behavioral and Molecular Modeling Studies
by: Lucja Kudla, et al.
Published: (2021-12-01) -
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
by: Ashish P. Thakrar, et al.
Published: (2023-02-01) -
Effect of Tramadol (μ-opioid receptor agonist) on orthodontic tooth movements in a rat model.
by: M Rashidpour, et al.
Published: (2012-06-01) -
Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
by: Liang Ye, et al.
Published: (2023-08-01)